特殊人群的疫苗接种:保护易感者
本文综述特殊人群疫苗接种的覆盖现状与影响因素,涉及早产儿、孕妇、慢性病及免疫受损者、因免疫衰老而风险升高者。尽管疫苗有效性和安全性已获证实,这些人群的接种率常低于预期,即使在美国等已有接种策略的发达国家也是如此;本文还归纳了接种不足的原因,并指出医务人员态度是影响接种决策的重要因素。
要点
- 孕妇流感疫苗接种率在发达国家很少超过50%,早产儿常规儿科疫苗全程接种率约为一半。
- 美国2014-2015年流感季65岁及以上人群流感疫苗接种率为67%,2013年破伤风与肺炎球菌疫苗为55-60%。
- 美国60岁及以上人群带状疱疹疫苗接种率仅为24%,多数其他国家更低。
核心结论
- 特殊人群疫苗覆盖不足,其原因包括对疫苗不良反应或致病的恐惧、接种不便与费用、对接种必要性或国家推荐缺乏认识,医务人员态度是影响接种决策的最重要因素之一。
- 需要提高医生对推荐的依从性,尤其在患者由多个亚专科医生诊疗、很少或未接受初级保健提供者照护的情况下。
研究设计与样本
- 本文为综述,围绕2011-2020年全球疫苗行动计划中免疫获益公平惠及所有人的战略目标,汇总特殊人群疫苗接种的覆盖现状与接种不足原因。
主要发现
- 孕妇流感疫苗接种率在发达国家很少超过50%,早产儿常规儿科疫苗接种及时率约为一半(原文称数据稀缺)。
- 美国2014-2015年流感季65岁及以上人群流感疫苗接种覆盖率为67%,2013年破伤风与肺炎球菌疫苗覆盖率为55-60%。
- 美国60岁及以上人群带状疱疹疫苗接种覆盖率仅为24%,多数其他国家接种率远低于此。
关键数值与推荐
- 2011-2020年全球疫苗行动计划的战略目标之一:免疫接种的获益应公平惠及所有人。
- 特殊人群包括早产儿、孕妇、慢性病与免疫受损者,以及因免疫衰老而疾病风险升高者。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
One of the strategic objectives of the 2011-2020 Global Vaccine Action Plan is for the benefits of immunisation to be equitably extended to all people. This approach encompasses special groups at increased risk of vaccine-preventable diseases, such as preterm infants and pregnant women, as well as those with chronic and immune-compromising medical conditions or at increased risk of disease due to immunosenescence. Despite demonstrations of effectiveness and safety, vaccine uptake in these special groups is frequently lower than expected, even in developed countries with vaccination strategies in place. For example, uptake of the influenza vaccine in pregnancy rarely exceeds 50% in developed countries and, although data are scarce, it appears that only half of preterm infants are up-to-date with routine paediatric vaccinations. Many people with chronic medical conditions or who are immunocompromised due to disease or aging are also under-vaccinated. In the US, coverage among people aged 65years or older was 67% for the influenza vaccine in the 2014-2015 season and 55-60% for tetanus and pneumococcal vaccines in 2013, while the coverage rate for herpes zoster vaccination among those aged 60years or older was only 24%. In most other countries, rates are far lower. Reasons for under-vaccination of special groups include fear of adverse outcomes or illness caused by the vaccine, the inconvenience (and in some settings, cost) of vaccination and lack of awareness of the need for vaccination or national recommendations. There is also evidence that healthcare providers' attitudes towards vaccination are among the most important influences on the decision to vaccinate. It is clear that physicians' adherence to recommendations needs to be improved, particularly where patients receive care from multiple subspecialists and receive little or no care from primary care providers.
引用
- Doherty M, Schmidt-Ott R, Santos JI, et al. Vaccination of special populations: Protecting the vulnerable. Vaccine. 2016. PMID: 27876197. doi:10.1016/j.vaccine.2016.11.015
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。